Editor LSA

Trader's Buzzers - Sauer Energy Inc (OTCMKTS:SENY), Applied DNA Sciences Inc (OTCBB:APDN) , NeoMedia Technologies, Inc. (OTCMKTS:NEOM), Cellceutix Corp (OTCBB:CTIX)

 

Lewes, DE -- (SBWIRE) -- 09/06/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Sauer Energy Inc (OTCMKTS:SENY), Applied DNA Sciences Inc (OTCBB:APDN) , NeoMedia Technologies, Inc. (OTCMKTS:NEOM), Cellceutix Corp (OTCBB:CTIX)

Sauer Energy Inc (OTCMKTS:SENY) is trading with an upsurge of 18.75%, along with the trading price of $0.190 up till now, while its today’s opening price was $0.17.

SENY recently gained a volume of 211,571.00 shares, while its average volume is 95,574.00 shares. The 52 week price range of the company is $0.08 - $0.40, while today, up until 3:05PM, its minimum price was $0.15.

Company’s 6 month’s performance gave an optimistic outlook overview as it gained 57.02%, while in its last 5 days its performance remained in the red with the plunge of -13.64%. Sauer Energy, Inc., a development stage company, engages in the design, development, manufacture, and distribution of vertical axis wind turbines (VAWT) for commercial and residential uses.

What was the Moving Force behind SENY On Bullish Run? Read This Research Report on SENY

Applied DNA Sciences Inc (OTCBB:APDN) stock hit its highest price at $0.13, after starting its trade at $0.13. Company reported an increase of 2.29% at the price of $0.125 recently and its current day range is from $0.12 to $0.13.

Nokia’s total market capitalization remained $92.95 million, along with the total outstanding shares of 744.22 million. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States.

For How Long APDN will Fight for Profitability? Read This Trend Analysis report

NeoMedia Technologies, Inc. (OTCMKTS:NEOM) recently soared 25.00% after opening at $0.003. Its current trading price is $0.0003. In the current session, the stocks gained total volume of 10.04 million shares up until now, whereas its average volume is 38.02 million shares.

Company’s most recent highest price in today’s trading session is $0.0004 while its minimum price was $0.0003.

For How Long neom Gloss will Attract Investors? Find out via this report

Cellceutix Corp (OTCBB:CTIX) opened day trade at $2.02 and showed a downtrend/uptrend and reached the price of $2.06 recently with the gain of +1.48%. Overall trading volume of the shares is 369,241.00 during the early hour of trading, while its average volume is 212,189.00 shares.

CTIX overall market capitalization is $192.87 million. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.

Will CTIX Continue To Move Higher? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/